• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ANGIOMED GMBH & CO. MEDIZINTECHNIK KG FLUENCY PLUS VASCULAR STENT GRAFT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ANGIOMED GMBH & CO. MEDIZINTECHNIK KG FLUENCY PLUS VASCULAR STENT GRAFT Back to Search Results
Catalog Number FVM08040
Device Problems Break (1069); Difficult to Remove (1528); Self-Activation or Keying (1557); Misfire (2532)
Patient Problems No Consequences Or Impact To Patient (2199); No Patient Involvement (2645)
Event Type  malfunction  
Manufacturer Narrative
The lot number for the malfunction was provided and a lot history review was performed.Based on the investigation of the returned catheter sample it could be confirmed that the user could only partially deploy the stent graft.The deployment mechanism was found in used condition, the stent graft was found partially deployed, and during evaluation testing a further deployment was impossible.The outer force transmitting catheter was found elongated which indicated that excessive release force must have been present during deployment attempt.An indication for a process related issue could not be found.Based on the information available, a definite root cause for the reported event could not be determined.The device is labeled for single use.
 
Event Description
This report summarizes one (1) malfunction.A review of the reported information indicated that model fvm12100 vascular stent graft allegedly experienced partial deployment and a difficult removal.This information was received from one source.This malfunction involved a patient with no known impact to the patient.The patient was a (b)(6) year old male weighing (b)(6) kgs.
 
Manufacturer Narrative
H10: the lot number for the malfunction was provided and a lot history review was performed.Based on the evaluation of the device sample returned a self-activation of the delivery system was confirmed, which led to the issue of blue pebax tip protruding from the outer sheath.This may have been misinterpreted by the customer as a missing blue tip due to a break.A break was not identified.A definite root cause for the issue identified could not be determined.Based on the information available, a definite root cause for the reported event could not be determined.The device is labeled for single use.H11: b5, d4, h6 (patient device).H11:section a through f - the information provided by bd represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.
 
Event Description
This report summarizes one malfunction.A review of the reported information indicated that model fvm08040 vascular stent graft allegedly experienced a break and self-activation.This information was received from a single source.There was no patient contact.The patient was a male, age and weight not provided.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
FLUENCY PLUS VASCULAR STENT GRAFT
Type of Device
VASCULAR STENT GRAFT
Manufacturer (Section D)
ANGIOMED GMBH & CO. MEDIZINTECHNIK KG
wachhausstrasse 6
karlsruhe 76227
GM  76227
MDR Report Key8809001
MDR Text Key151643764
Report Number9681442-2019-00130
Device Sequence Number1
Product Code PFV
UDI-Device Identifier00801741145827
UDI-Public(01)00801741145827
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Type of Report Initial,Followup
Report Date 10/08/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator No Information
Device Catalogue NumberFVM08040
Device Lot NumberANBS1645
Initial Date Manufacturer Received 06/30/2019
Initial Date FDA Received07/19/2019
Supplement Dates Manufacturer Received09/30/2019
Supplement Dates FDA Received10/08/2019
Patient Sequence Number1
-
-